Skip to content

South Korean study to prevent cognitive impairment and protect brain health through multidomain interventions via face-to-face and video communication platforms in mild cognitive impairment (SUPERBRAIN-MEET): A randomized controlled trial.

Randomized controlled trial · Alzheimers Dement · 2025. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 39840755

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

South Korean study to prevent cognitive impairment and protect brain health through multidomain interventions via face-to-face and video communication platforms in mild cognitive impairment (SUPERBRAIN-MEET): A randomized controlled trial.

Moon SY, Park YK, Jeong JH et al.
Alzheimers Dement · 2025

PubMed ID
39840755
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.